JY
STAB

Jeff Yass’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Jeff Yass’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,200
Closed -$24K – 14271
2021
Q3 		$24K Buy
+10,200
New +$38.6K ﹤0.01% 12521
2014
Q2 		– Sell
-1,055
Closed -$14K – 10215
2014
Q1 		$14K Sell
1,055
-30
-3% -$489 ﹤0.01% 8801
2013
Q4 		$25K Sell
1,085
-600
-36% -$16.3K ﹤0.01% 8883
2013
Q3 		$53K Sell
1,685
-600
-26% -$19.8K ﹤0.01% 8226
2013
Q2 		$72K Buy
+2,285
New +$78.7K ﹤0.01% 7887

Other funds holding STAB

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Jeff Yass's STAB Position: Q4 2022 in Review

Jeff Yass sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q4 2022, closing a stake of 16,228 shares — an estimated $2K sold.

Jeff Yass first reported a position in STAB in Q2 2013 and held it in 13 quarters. The position peaked at $131K in Q2 2021. 29 funds tracked by Wall St. Rank hold STAB as of Q4 2022.

  • Jeff Yass reported no remaining Statera Biopharma, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Jeff Yass sold 16,228 Statera Biopharma, Inc. Common Stock shares in Q4 2022, an estimated $2K.
  • Jeff Yass first reported a position in Statera Biopharma, Inc. Common Stock in Q2 2013 and held it in 13 quarters.
  • Jeff Yass's Statera Biopharma, Inc. Common Stock position peaked at $131K in Q2 2021.
  • 29 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.